{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:05:11Z","timestamp":1793747111234,"version":"4.6.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12281-8","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:53:51Z","timestamp":1764867231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Containment and response strategies for mpox outbreaks: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Lundi-Anne","family":"Omam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farihah","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Kamwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Mba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"10","key":"12281_CR1","doi-asserted-by":"publisher","first-page":"e0007791","DOI":"10.1371\/journal.pntd.0007791","volume":"13","author":"EM Beer","year":"2019","unstructured":"Beer EM, Rao VB. A systematic review of the epidemiology of human Monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019;13(10):e0007791.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"12281_CR2","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox\u2014A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.","journal-title":"PLoS Negl Trop Dis"},{"key":"12281_CR3","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.ijmmb.2024.100704","volume":"51","author":"N Derhab","year":"2024","unstructured":"Derhab N. Human Monkeypox virus: A systematic critical review during the pandemic peak. Ind J Med Microbiol. 2024;51:C7\u2013100704.","journal-title":"Ind J Med Microbiol"},{"issue":"8","key":"12281_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 Countries \u2014 April\u2013June 2022. N Engl J Med. 2022;387(8):679\u201391.","journal-title":"N Engl J Med"},{"key":"12281_CR5","doi-asserted-by":"publisher","first-page":"100312","DOI":"10.1016\/j.puhip.2022.100312","volume":"4","author":"EL Jarman","year":"2022","unstructured":"Jarman EL, Alain M, Conroy N, Omam LA. A case report of Monkeypox as a result of conflict in the context of a measles campaign. Public Health Pract. 2022;4:100312.","journal-title":"Public Health Pract"},{"key":"12281_CR6","first-page":"C7","volume":"34","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Padovese V, Folch C, Rossoni I, Marks M, Rodr\u00edguez i Arias MA, et al. Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging stis in Europe. Lancet Reg Health - Europe. 2023;34:C7\u2013100742.","journal-title":"Lancet Reg Health - Europe"},{"issue":"10370","key":"12281_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Ogoina D, Titanji BK, Galvan C, Muyembe J-J, Marks M, et al. Monkeypox Lancet. 2023;401(10370):60\u201374.","journal-title":"Monkeypox Lancet"},{"issue":"6","key":"12281_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11904-023-00682-w","volume":"20","author":"J Zucker","year":"2023","unstructured":"Zucker J, Hazra A, Titanji BK. Mpox and HIV\u2014Collision of two diseases. Curr HIV\/AIDS Rep. 2023;20(6):440\u201350.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"19","key":"12281_CR9","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2024.21091","volume":"332","author":"BK Titanji","year":"2024","unstructured":"Titanji BK, Hazra A, Zucker J. Mpox clinical Presentation, diagnostic Approaches, and treatment strategies: A review. JAMA. 2024;332(19):1652\u201362.","journal-title":"JAMA"},{"key":"12281_CR10","doi-asserted-by":"publisher","first-page":"101030","DOI":"10.1016\/j.onehlt.2025.101030","volume":"20","author":"A Bogacka","year":"2025","unstructured":"Bogacka A, Wroczynska A, Rymer W, Grzesiowski P, Kant R, Grzybek M, et al. Mpox unveiled: global epidemiology, treatment advances, and prevention strategies. One Health. 2025;20:101030.","journal-title":"One Health"},{"issue":"10473","key":"12281_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(24)02681-3","volume":"405","author":"N Ndembi","year":"2025","unstructured":"Ndembi N, Boum Y, Fol\u00e1yan MO. The first 100 days of the Mpox response in Africa. Lancet. 2025;405(10473):121\u20132.","journal-title":"Lancet"},{"issue":"1","key":"12281_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.24-0606","volume":"112","author":"A Zumla","year":"2025","unstructured":"Zumla A, Rosenthal PJ, Sam-Agudu NA, Ogoina D, Mbala-Kingebeni P, Ntoumi F, et al. The 2024 public health emergency of international concern: A global failure to control Mpox. Am J Trop Med Hyg. 2025;112(1):17\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"12281_CR13","doi-asserted-by":"publisher","first-page":"e1577","DOI":"10.1016\/S2214-109X(24)00363-2","volume":"12","author":"N Ndembi","year":"2024","unstructured":"Ndembi N, Folayan MO, Ngongo N, Ntoumi F, Ogoina D, El Rabbat M, et al. Mpox outbreaks in Africa constitute a public health emergency of continental security. Lancet Global Health. 2024;12(10):e1577\u20139.","journal-title":"Lancet Global Health"},{"key":"12281_CR14","unstructured":"World Health Organization. WHO Director-general declares mpox outbreak a public health emergency of international concern. 2024."},{"issue":"3","key":"12281_CR15","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/v15030727","volume":"15","author":"M Curaudeau","year":"2023","unstructured":"Curaudeau M, Besombes C, Nakoun\u00e9 E, Fontanet A, Gessain A, Hassanin A. Identifying the most probable mammal reservoir hosts for Monkeypox virus based on ecological niche comparisons. Viruses. 2023;15(3):C7\u2013727.","journal-title":"Viruses"},{"issue":"12","key":"12281_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S1473-3099(23)00487-5","volume":"23","author":"E Nakoune","year":"2023","unstructured":"Nakoune E, Yagata FEM, Nimbona A, Belizaire M-RD, Boum Y. Mpox: interdependence and inequity. Lancet Infect Dis. 2023;23(12):1335\u20136.","journal-title":"Lancet Infect Dis"},{"key":"12281_CR17","unstructured":"World Health Organization. WHO Mpox Outbreak Toolkit 2024 [Available from: https:\/\/www.who.int\/emergencies\/outbreak-toolkit\/disease-outbreak-toolboxes\/mpox-outbreak-toolbox."},{"key":"12281_CR18","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.soh.2024.100085","volume":"3","author":"DB Olawade","year":"2024","unstructured":"Olawade DB, Wada OZ, Fidelis SC, Oluwole OS, Alisi CS, Orimabuyaku NF, et al. Strengthening africa\u2019s response to Mpox (monkeypox): insights from historical outbreaks and the present global spread. Sci One Health. 2024;3:100085.","journal-title":"Sci One Health"},{"key":"12281_CR19","unstructured":"World Health Organization. The Global Strategic Preparedness and Response Plan (SPRP) for mpox. 2024."},{"key":"12281_CR20","doi-asserted-by":"crossref","unstructured":"Ngo Bibaa LO. Primary health care beyond COVID-19: dealing with the pandemic in Cameroon. BJGP Open. 2020;4(4).","DOI":"10.3399\/bjgpopen20X101113"},{"issue":"1","key":"12281_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12916-019-1338-1","volume":"17","author":"L Sigfrid","year":"2019","unstructured":"Sigfrid L, Moore C, Salam AP, Maayan N, Hamel C, Garritty C, et al. A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks\u2014results from the Lassa fever pilot. BMC Med. 2019;17(1):107.","journal-title":"BMC Med"},{"key":"12281_CR22","unstructured":"Critical Appraisal Skills. program 2021. Available from: https:\/\/casp-uk.net\/."},{"key":"12281_CR23","unstructured":"Studies AXIS. CAtfC-S. Critical appraisal tool for cross-sectional studies (AXIS)."},{"issue":"6","key":"12281_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/09564624231155995","volume":"34","author":"M Tweed","year":"2023","unstructured":"Tweed M, Fortescue-Talwar K, Finn R, Buonsenno L, Nichols K, Frem J, et al. Delivering a community-based monkeypox vaccination programme in partnership. Int J STD AIDS. 2023;34(6):427\u20139.","journal-title":"Int J STD AIDS"},{"issue":"21","key":"12281_CR25","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.2807\/1560-7917.ES.2024.29.21.2300555","volume":"29","author":"L Reques","year":"2024","unstructured":"Reques L, Mercuriali L, Silu\u00e9 Y, Chazelle E, Spaccaferri G, Velter A, et al. Mpox in children and adolescents and contact follow-up in school settings in greater Paris, France, May 2022 to July 2023. Eurosurveillance. 2024;29(21):C7\u20132300555.","journal-title":"Eurosurveillance"},{"key":"12281_CR26","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.1093\/infdis\/jiad533","volume":"229","author":"H Sachdeva","year":"2024","unstructured":"Sachdeva H, Shahin R, Ota S, Isabel S, Mangat CS, Stuart R, et al. Preparing for Mpox resurgence: surveillance lessons from outbreaks in Toronto, Canada. J Infect Dis. 2024;229:S305\u201312.","journal-title":"J Infect Dis"},{"issue":"6","key":"12281_CR27","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/v15061384","volume":"15","author":"K Mellou","year":"2023","unstructured":"Mellou K, Tryfinopoulou K, Pappa S, Gkolfinopoulou K, Papanikou S, Papadopoulou G, et al. Overview of Mpox outbreak in Greece in 2022\u20132023: is it over? Viruses. 2023;15(6):C7\u20131384.","journal-title":"Viruses"},{"issue":"2","key":"12281_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.15585\/mmwr.mm7302a4","volume":"73","author":"CM Leonard","year":"2024","unstructured":"Leonard CM, Poortinga K, Nguyen E, Karan A, Kulkarni S, Cohen R, et al. Mpox Outbreak \u2014 Los Angeles County, California, May 4\u2013August 17, 2023. Morb Mortal Wkly Rep. 2024;73(2):44\u20138.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"20","key":"12281_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15585\/mmwr.mm7220a2","volume":"72","author":"JH McQuiston","year":"2023","unstructured":"McQuiston JH, Braden CR, Bowen MD, McCollum AM, McDonald R, Carnes N, et al. The CDC domestic Mpox Response \u2014 United States, 2022\u20132023. Morb Mortal Wkly Rep. 2023;72(20):547\u201352.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"12281_CR30","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1038\/s41467-024-46590-4","volume":"15","author":"G Guzzetta","year":"2024","unstructured":"Guzzetta G, Marziano V, Mammone A, Siddu A, Ferraro F, Caraglia A, et al. The decline of the 2022 Italian Mpox epidemic: role of behavior changes and control strategies. Nat Commun. 2024;15(1):C7\u20132283.","journal-title":"Nat Commun"},{"issue":"24","key":"12281_CR31","first-page":"546","volume":"73","author":"MJ O\u2019Neil","year":"2024","unstructured":"O\u2019Neil MJ, Archer R, Danza P, Fisher R, Bagwell DA, Younis I, et al. Successful distribution of Tecovirimat during the peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023. MMWR Morbidity Mortal Wkly Rep. 2024;73(24):546\u201350.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"issue":"6","key":"12281_CR32","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/vaccines12060651","volume":"12","author":"S Back","year":"2024","unstructured":"Back S, Knox B, Coakley C, Deltour N, Jacquot E, Raad H, et al. Effectiveness and safety of the MVA\u2013BN vaccine against mpox in at-risk individuals in the United States (USMVAc). Vaccines. 2024;12(6):C7\u2013651.","journal-title":"Vaccines"},{"key":"12281_CR33","doi-asserted-by":"crossref","unstructured":"Perez Duque M, Ribeiro S, Martins JV, Casaca P, Leite PP, Tavares M, et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill. 2022;27(22).","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200424"},{"issue":"19","key":"12281_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.15585\/mmwr.mm7319a3","volume":"73","author":"JH McQuiston","year":"2024","unstructured":"McQuiston JH, Luce R, Kazadi DM, Bwangandu CN, Mbala-Kingebeni P, Anderson M, et al. U.S. Preparedness and response to increasing clade I Mpox cases in the Democratic Republic of the Congo - United States, 2024. Morb Mortal Wkly Rep. 2024;73(19):435\u201340.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"12281_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/09564624231223764","volume":"35","author":"SE Thomassen","year":"2024","unstructured":"Thomassen SE, von Schreeb S, Kirkby NS, Pinholt M, Lebech AM, Kronborg G, et al. Prospective screening for Monkeypox infection among users of HIV pre-exposure prophylaxis in Denmark. Int J STD AIDS. 2024;35(5):374\u20138.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"12281_CR36","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1186\/s12879-024-09510-x","volume":"24","author":"U Koppe","year":"2024","unstructured":"Koppe U, Jansen K, Schmidt AJ, Weber C, Schulze H, Kulis-Horn RK, et al. Clinically inapparent Mpox virus (MPXV) infections among clients of three anonymous community based voluntary counselling and testing centres in Berlin, Germany, 2022\u20132023. BMC Infect Dis. 2024;24(1):C7\u2013613.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"12281_CR37","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/cid\/ciac889","volume":"76","author":"M Ubals","year":"2023","unstructured":"Ubals M, Tar\u00edn-Vicente EJ, Oller X, Mendoza A, Alemany A, Hern\u00e1ndez-Rodr\u00edguez \u00c1, et al. Evaluating the accuracy of Self-Collected swabs for the diagnosis of Mpox. Clin Infect Dis. 2023;76(7):1311\u20134.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"12281_CR38","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/pathogens12070916","volume":"12","author":"E Kinganda-Lusamaki","year":"2023","unstructured":"Kinganda-Lusamaki E, Baketana LK, Ndomba-Mukanya E, Bouillin J, Thaurignac G, Aziza AA, et al. Use of Mpox multiplex serology in the identification of cases and outbreak investigations in the Democratic Republic of the congo (DRC). Pathogens. 2023;12(7):C7\u2013916.","journal-title":"Pathogens"},{"issue":"2","key":"12281_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4269\/ajtmh.16-0567","volume":"96","author":"D Li","year":"2017","unstructured":"Li D, Wilkins K, McCollum AM, Osadebe L, Kabamba J, Nguete B, et al. Evaluation of the GeneXpert for human Monkeypox diagnosis. Am J Trop Med Hyg. 2017;96(2):405\u201310.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"12281_CR40","first-page":"C7","volume":"109","author":"SB Irma","year":"2024","unstructured":"Irma SB, Edina Z, Azra \u010c, Amela DL. Mpox virus DNA detection in different clinical specimens: tertiary-level laboratory experience, Bosnia and Herzegovina, 2022. Diagn Microbiol Infect Dis. 2024;109(2):C7\u2013116268.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"12281_CR41","doi-asserted-by":"publisher","first-page":"105447","DOI":"10.1016\/j.jcv.2023.105447","volume":"163","author":"A Ma","year":"2023","unstructured":"Ma A, Bradley BT. Clinical testing of pediatric Mpox specimens: unique features and challenges in a low prevalence population. J Clin Virol. 2023;163:105447.","journal-title":"J Clin Virol"},{"issue":"5","key":"12281_CR42","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/v15051107","volume":"15","author":"S Algarate","year":"2023","unstructured":"Algarate S, Bueno J, Crusells MJ, Ara M, Alonso H, Alvarado E, et al. Usefulness of Non-Skin samples in the PCR diagnosis of Mpox (Monkeypox). Viruses. 2023;15(5):C7\u20131107.","journal-title":"Viruses"},{"issue":"1","key":"12281_CR43","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1186\/s40246-024-00581-0","volume":"18","author":"Y Li","year":"2024","unstructured":"Li Y, Miyani B, Faust RA, David RE, Xagoraraki I. A broad wastewater screening and clinical data surveillance for virus-related diseases in the metropolitan Detroit area in Michigan. Hum Genomics. 2024;18(1):C7\u201314.","journal-title":"Hum Genomics"},{"issue":"2","key":"12281_CR44","doi-asserted-by":"publisher","first-page":"116268","DOI":"10.1016\/j.diagmicrobio.2024.116268","volume":"109","author":"EZ I S-B","year":"2024","unstructured":"I S-B EZ. A D-L. Mpox virus DNA detection in different clinical specimens: tertiary-level laboratory experience, Bosnia and Herzegovina, 2022. Diagn Microbiol Infect Dis. 2024;109(2):116268.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"12281_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/PHH.0000000000001870","volume":"30","author":"S Crouch","year":"2024","unstructured":"Crouch S, Jalil E, Pierce AB, Baptista M, Wong E, Stuart R. Mpox management: A holistic local response to a global threat. J Public Health Manage Pract. 2024;30(2):204\u20137.","journal-title":"J Public Health Manage Pract"},{"key":"12281_CR46","doi-asserted-by":"crossref","unstructured":"Ciccarese G, Fortunato F, Caputo SL, Santantonio T, Herzum A, Drago F. Relapse of inflammatory skin diseases following vaccination against Monkeypox. J Med Virol. 2023;95(11 C7 - e29239).","DOI":"10.1002\/jmv.29239"},{"key":"12281_CR47","doi-asserted-by":"crossref","unstructured":"Polk C, Sampson M, Fairman RT, DeWitt ME, Leonard M, Neelakanta A et al. Evaluation of a health system\u2019s implementation of a monkeypox care model under the RE-AIM framework. Therapeutic Adv Infect Disease. 2023;10.","DOI":"10.1177\/20499361231158463"},{"issue":"6","key":"12281_CR48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jiac.2023.11.025","volume":"30","author":"Y Akiyama","year":"2024","unstructured":"Akiyama Y, Morioka S, Tsuzuki S, Yoshikawa T, Yamato M, Nakamura H, et al. Efficacy and viral dynamics of Tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan. J Infect Chemother. 2024;30(6):488\u201393.","journal-title":"J Infect Chemother"},{"issue":"5","key":"12281_CR49","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s15010-023-02049-0","volume":"51","author":"L Hermanussen","year":"2023","unstructured":"Hermanussen L, Brehm TT, Wolf T, Boesecke C, Schlabe S, Borgans F, et al. Tecovirimat for the treatment of severe Mpox in Germany. Infection. 2023;51(5):1563\u20138.","journal-title":"Infection"},{"issue":"5","key":"12281_CR50","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jaad.2022.10.043","volume":"88","author":"TG Sobral-Costas","year":"2023","unstructured":"Sobral-Costas TG, Escudero-Tornero R, Servera-Negre G, Bernardino JI, Guti\u00e9rrez Arroyo A, D\u00edaz-Men\u00e9ndez M, et al. Human Monkeypox outbreak: epidemiological data and therapeutic potential of topical Cidofovir in a prospective cohort study. J Am Acad Dermatol. 2023;88(5):1074\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"12281_CR51","doi-asserted-by":"crossref","unstructured":"Vo C, Zomorodi R, Silvera R, Bartram L, Lugo LA, Kojic E, et al. Clinical characteristics and outcomes of patients with Mpox who received Tecovirimat in a New York City health system. Open Forum Infect Dis. 2023;10(11 C7 - ofad552).","DOI":"10.1093\/ofid\/ofad552"},{"issue":"5","key":"12281_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/PHH.0000000000002010","volume":"30","author":"ML Ouyang","year":"2024","unstructured":"Ouyang ML, Marusinec R, Bayard PJ, Edmunds M, Johnson M, Lai S, et al. Epidemiology of Mpox Cases, and Tecovirimat and JYNNEOS Utilization, Alameda County, California, June-October 2022. J Public Health Manage Pract. 2024;30(5):744\u201352.","journal-title":"J Public Health Manage Pract"},{"issue":"20","key":"12281_CR53","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.vaccine.2024.05.035","volume":"42","author":"N Yeganeh","year":"2024","unstructured":"Yeganeh N, Yin S, Moir O, Danza P, Kim M, Finn L, et al. Effectiveness of JYNNEOS vaccine against symptomatic Mpox disease in adult men in Los Angeles County, August 29, 2022 to January 1, 2023. Vaccine. 2024;42(20):C7\u2013125987.","journal-title":"Vaccine"},{"issue":"36","key":"12281_CR54","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15585\/mmwr.mm7236a4","volume":"72","author":"S Schildhauer","year":"2023","unstructured":"Schildhauer S, Saadeh K, Vance J, Quint J, Salih T, Lo T, et al. Reduced odds of Mpox-Associated hospitalization among persons who received JYNNEOS Vaccine - California, May 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023;72(36):992\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"12281_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","volume":"72","author":"ES Rosenberg","year":"2023","unstructured":"Rosenberg ES, Dorabawila V, Hart-Malloy R, Anderson BJ, Miranda W, O\u2019Donnell T, et al. Effectiveness of JYNNEOS vaccine against diagnosed Mpox Infection \u2014 New York, 2022. Morb Mortal Wkly Rep. 2023;72(20):559\u201363.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"12281_CR56","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.vaccine.2023.12.066","volume":"42","author":"JB Rosen","year":"2024","unstructured":"Rosen JB, Arciuolo RJ, Pathela P, Boyer CB, Baumgartner J, Latash J, et al. JYNNEOS\u2122 effectiveness as post-exposure prophylaxis against mpox: challenges using real-world outbreak data. Vaccine. 2024;42(3):548\u201355.","journal-title":"Vaccine"},{"key":"12281_CR57","doi-asserted-by":"crossref","unstructured":"Ramchandani MS, Berzkalns A, Cannon CA, Dombrowski JC, Brown E, Chow EJ, et al. Effectiveness of the modified vaccinia Ankara vaccine against Mpox in men who have sex with men: a retrospective cohort analysis, seattle, Washington. Open Forum Infect Dis. 2023;10(11 C7 - ofad528).","DOI":"10.1093\/ofid\/ofad528"},{"issue":"7","key":"12281_CR58","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/vaccines11071138","volume":"11","author":"AJL Piccolo","year":"2023","unstructured":"Piccolo AJL, Chan J, Cohen GM, Mgbako O, Pitts RA, Postelnicu R, et al. Critical elements of an Mpox vaccination model at the largest public health hospital system in the united States. Vaccines. 2023;11(7):C7\u20131138.","journal-title":"Vaccines"},{"key":"12281_CR59","doi-asserted-by":"crossref","unstructured":"Irshad U, Bishop D, Mullis C, Toro J, Zingman BS, Meyerowitz EA. Implementation of an mpox vaccination program at a large sexual health clinic in the Bronx-Lessons in vaccine equity. Open Forum Infect Dis. 2023;10(11 C7 - ofad544).","DOI":"10.1093\/ofid\/ofad544"},{"key":"12281_CR60","doi-asserted-by":"crossref","unstructured":"Haverkate MR, Willemstein IJM, van Ewijk CE, Adam PCG, Lanooij SJ, Jonker-Jorna P, et al. Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023. Eurosurveillance. 2024;29(21).","DOI":"10.2807\/1560-7917.ES.2024.29.21.2300608"},{"issue":"26","key":"12281_CR61","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","volume":"388","author":"NP Deputy","year":"2023","unstructured":"Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, et al. Vaccine effectiveness of JYNNEOS against Mpox disease in the united States. N Engl J Med. 2023;388(26):2434\u201343.","journal-title":"N Engl J Med"},{"issue":"20","key":"12281_CR62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","volume":"72","author":"AF Dalton","year":"2023","unstructured":"Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, et al. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: A multijurisdictional Case-Control Study \u2014 United States, August 19, 2022\u2013March 31, 2023. Morb Mortal Wkly Rep. 2023;72(20):553\u20138.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"12281_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jiph.2024.02.015","volume":"17","author":"R Allard","year":"2024","unstructured":"Allard R, Leclerc P, Bergeron G, Cadieux G. Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations. J Infect Public Health. 2024;17(4):676\u201380.","journal-title":"J Infect Public Health"},{"key":"12281_CR64","doi-asserted-by":"crossref","unstructured":"Agunbiade S, Burton F, Muirhead J, Whitlock GG, Girometti N. Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation. Sex Transm Infect C7 - sextrans-2022-055698. 2023.","DOI":"10.1136\/sextrans-2022-055698"},{"key":"12281_CR65","doi-asserted-by":"crossref","unstructured":"Dimitrov D, Adamson B, Matrajt L. Evaluation of mpox vaccine dose-sparing strategies. PNAS Nexus. 2023;2(5 C7 - pgad095).","DOI":"10.1093\/pnasnexus\/pgad095"},{"key":"12281_CR66","doi-asserted-by":"crossref","unstructured":"Morales LM, del Buey JFB, Garc\u00eda MA, Largo NC, Juli\u00e1 AN, Torres MCV, et al. Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022. Eurosurveillance. 2023;28(24).","DOI":"10.2807\/1560-7917.ES.2023.28.24.2200883"},{"issue":"7","key":"12281_CR67","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(23)00057-9","volume":"23","author":"M Bertran","year":"2023","unstructured":"Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA\u2013BN smallpox vaccine against Mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23(7):828\u201335.","journal-title":"Lancet Infect Dis"},{"key":"12281_CR68","first-page":"C7","volume":"45","author":"J Ghosn","year":"2024","unstructured":"Ghosn J, Assoumou L, Ouattara M, Rubenstein E, Pialoux G, Katlama C, et al. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on Mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. Lancet Reg Health - Europe. 2024;45:C7\u2013101020.","journal-title":"Lancet Reg Health - Europe"},{"key":"12281_CR69","doi-asserted-by":"crossref","unstructured":"Payne AB, Ray LC, Kugeler KJ, Fothergill A, White EB, Canning M, et al. Incidence of monkeypox among unvaccinated persons compared with persons receiving\u2009\u2265\u20091 JYNNEOS Vaccine Dose \u2014 32 U.S. Jurisdictions, July 31\u2013September 3, 2022 | MMWR. @CDCMMWR; 2022 2022-10-05T06:37:54Z.","DOI":"10.15585\/mmwr.mm7140e3"},{"issue":"50","key":"12281_CR70","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200882","volume":"27","author":"Y Merad","year":"2022","unstructured":"Merad Y, Gaymard A, Cotte L, Perpoint T, Alfaiate D, Godinot M, et al. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022. Eurosurveillance. 2022;27(50):C7\u20132200882.","journal-title":"Eurosurveillance"},{"issue":"2","key":"12281_CR71","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/cid\/ciad645","volume":"78","author":"M Font\u00e1n-Vela","year":"2024","unstructured":"Font\u00e1n-Vela M, Hernando V, Olmedo C, Coma E, Mart\u00ednez M, Moreno-Perez D, et al. Effectiveness of modified vaccinia Ankara-Bavaria nordic vaccination in a population at high risk of mpox: A Spanish cohort study. Clin Infect Dis. 2024;78(2):476\u201383.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"12281_CR72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.15585\/mmwr.mm7215a4","volume":"72","author":"KK Kota","year":"2023","unstructured":"Kota KK, Hong J, Zelaya C, Riser AP, Rodriguez A, Weller DL, et al. Racial and ethnic disparities in Mpox cases and vaccination among adult Males - United States, May-December 2022. MMWR Morb Mortal Wkly Rep. 2023;72(15):398\u2013403.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"12281_CR73","doi-asserted-by":"crossref","unstructured":"Navarro C, Lau C, Buchan SA, Burchell AN, Nasreen S, Friedman L, et al. Effectiveness of one dose of MVA-BN vaccine against mpox infection in males in Ontario, Canada: a target trial emulation. medRxiv. 2023:2023.10.04.23296566.","DOI":"10.1101\/2023.10.04.23296566"},{"key":"12281_CR74","doi-asserted-by":"crossref","unstructured":"Alavian N, Mourad A, Woodhouse EW, Niehaus E, Cunningham H, Zavala S, et al. Disparities in mpox vaccination among priority populations during the 2022 outbreak. Open Forum Infect Dis. 2023;10(9 C7 - ofad434).","DOI":"10.1093\/ofid\/ofad434"},{"issue":"1","key":"12281_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/PHH.0000000000001818","volume":"30","author":"GJ Bautista","year":"2024","unstructured":"Bautista GJ, Madera-Garcia V, Carter RJ, Schwitters A, Byrkit R, Carnes N, et al. Reducing vaccination disparities during a National emergency response: the US Mpox vaccine equity pilot program. J Public Health Manage Pract. 2024;30(1):122\u20139.","journal-title":"J Public Health Manage Pract"},{"issue":"12","key":"12281_CR76","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.3390\/vaccines11121761","volume":"11","author":"G Del Duca","year":"2023","unstructured":"Del Duca G, Tavelli A, Mastrorosa I, Aguglia C, Lanini S, Brita AC, et al. Risk awareness as a key determinant of early vaccine uptake in the mpox vaccination campaign in an Italian region: a cross-sectional analysis. Vaccines. 2023;11(12):C7\u20131761.","journal-title":"Vaccines"},{"issue":"3","key":"12281_CR77","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.focus.2024.100204","volume":"3","author":"A Bakshi","year":"2024","unstructured":"Bakshi A, McClure J, Sokol T, Mendoza L, Adhikari A, Zhao N, et al. Pivoting COVID-19 resources for an equitable Mpox vaccine response in Louisiana. AJPM Focus. 2024;3(3):C7\u2013100204.","journal-title":"AJPM Focus"},{"issue":"43","key":"12281_CR78","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15585\/mmwr.mm7143e2","volume":"71","author":"JL Kriss","year":"2022","unstructured":"Kriss JL, Boersma PM, Martin E, Reed K, Adjemian J, Smith N, et al. Receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox - United States, May 22-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(43):1374\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"12281_CR79","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","volume":"29","author":"Y Wolff Sagy","year":"2023","unstructured":"Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, et al. Real-world effectiveness of a single dose of Mpox vaccine in males. Nat Med. 2023;29(3):748\u201352.","journal-title":"Nat Med"},{"issue":"23","key":"12281_CR80","doi-asserted-by":"publisher","first-page":"627","DOI":"10.15585\/mmwr.mm7223a3","volume":"72","author":"KK Kota","year":"2023","unstructured":"Kota KK, Chesson H, Hong J, Zelaya C, Spicknall IH, Riser AP, et al. Progress toward equitable Mpox vaccination coverage: A shortfall Analysis - United States, May 2022-April 2023. MMWR Morb Mortal Wkly Rep. 2023;72(23):627\u201332.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"12281_CR81","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/imj.16236","volume":"53","author":"VJ Cornelisse","year":"2023","unstructured":"Cornelisse VJ, Heath-Paynter D, Delpech V, Read P, Apostolellis A, Medland NA, et al. How Australia and Aotearoa new Zealand avoided large-scale Mpox (formerly monkeypox) outbreaks in 2022\u20132023. Intern Med J. 2023;53(10):1732\u20138.","journal-title":"Intern Med J"},{"issue":"30","key":"12281_CR82","doi-asserted-by":"publisher","first-page":"827","DOI":"10.15585\/mmwr.mm7230a4","volume":"72","author":"T Salih","year":"2023","unstructured":"Salih T, Vance J, Quint J, Meza B, McNitt L, Lincoln WU, et al. Demographic disparities in Mpox vaccination series Completion, by route of vaccine Administration - California, August 9, 2022-March 31, 2023. Morb Mortal Wkly Rep. 2023;72(30):827\u201332.","journal-title":"Morb Mortal Wkly Rep"},{"key":"12281_CR83","doi-asserted-by":"crossref","unstructured":"van Ewijk CE, Smit C, Bavalia R, Ainslie K, Vollaard A, van Rijckevorsel G, et al. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, The Netherlands, May\u2013July. 2022. Vaccine. 2023;41(47):6952-9.","DOI":"10.1016\/j.vaccine.2023.10.013"},{"key":"12281_CR84","doi-asserted-by":"crossref","unstructured":"Zeien J, Vieira J, Hanna J, Surendra L, Stenzel J, Ramirez A et al. Mpox case reports in an urban homeless population and a proof of concept for a street-based mobile mpox vaccination clinic. J Prim Care Community Health. 2023;14.","DOI":"10.1177\/21501319231169991"},{"issue":"1","key":"12281_CR85","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/cid\/ciae181","volume":"79","author":"EAG Faherty","year":"2024","unstructured":"Faherty EAG, Holly T, Ogale YP, Spencer H, Becht AM, Crisler G, et al. Investigation of an Mpox outbreak affecting many vaccinated persons in Chicago, Illinois\u2014March 2023\u2013June 2023. Clin Infect Dis. 2024;79(1):122\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"12281_CR86","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/pathogens12091079","volume":"12","author":"F Passini","year":"2023","unstructured":"Passini F, Raccagni AR, Diotallevi S, Lolatto R, Bruzzesi E, Candela C, et al. Mpox outbreak 2022: A comparative analysis of the characteristics of individuals receiving MVA-BN vaccination and people diagnosed with Mpox infection in Milan, Italy. Pathogens. 2023;12(9):C7\u20131079.","journal-title":"Pathogens"},{"key":"12281_CR87","doi-asserted-by":"crossref","unstructured":"Back S, Knox B, Coakley C, Deltour N, Jacquot E, Raad H, et al. Effectiveness and safety of the MVA-BN vaccine against mpox in at-risk individuals in the United States (USMVAc). Vaccines (Basel). 2024;12(6).","DOI":"10.3390\/vaccines12060651"},{"issue":"3","key":"12281_CR88","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/00333549231201682","volume":"139","author":"LT Allan-Blitz","year":"2024","unstructured":"Allan-Blitz LT, Khan T, Elangovan K, Smith K, Multani A, Mayer KH. Addressing Mpox at a frontline community health center: lessons for the next outbreak. Public Health Rep. 2024;139(3):294\u2013300.","journal-title":"Public Health Rep"},{"issue":"1","key":"12281_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12879-023-08083-5","volume":"23","author":"S Yang","year":"2023","unstructured":"Yang S, Guo X, Zhao Z, Abudunaibi B, Zhao Y, Rui J, et al. Possibility of Mpox viral transmission and control from high-risk to the general population: a modeling study. BMC Infect Dis. 2023;23(1):119.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12281_CR90","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s15010-023-01997-x","volume":"51","author":"ST Kr\u00f6ger","year":"2023","unstructured":"Kr\u00f6ger ST, Lehmann MC, Treutlein M, Fiethe A, Kossow A, K\u00fcfer-Wei\u00df A, et al. Mpox outbreak 2022: an overview of all cases reported to the Cologne health department. Infection. 2023;51(5):1369\u201381.","journal-title":"Infection"},{"key":"12281_CR91","doi-asserted-by":"crossref","unstructured":"Del Duca G, Tavelli A, Mastrorosa I, Aguglia C, Lanini S, Brita AC, et al. Risk awareness as a key determinant of early vaccine uptake in the mpox vaccination campaign in an Italian region: a cross-sectional analysis. Vaccines (Basel). 2023;11(12).","DOI":"10.3390\/vaccines11121761"},{"issue":"1","key":"12281_CR92","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1186\/s12879-023-08083-5","volume":"23","author":"S Yang","year":"2023","unstructured":"Yang S, Guo X, Zhao Z, Abudunaibi B, Zhao Y, Rui J, et al. Possibility of Mpox viral transmission and control from high-risk to the general population: a modeling study. BMC Infect Dis. 2023;23(1):C7\u2013119.","journal-title":"BMC Infect Dis"},{"key":"12281_CR93","doi-asserted-by":"crossref","unstructured":"Rainey JJ, Lin XM, Murphy S, Velazquez-Kronen R, Do T, Hughes C, et al. Deployment of the national notifiable diseases surveillance system during the 2022-23 mpox outbreak in the United States -opportunities and challenges with case notifications during public health emergencies. PLoS One. 2024;19(4 April C7 - e0300175).","DOI":"10.1371\/journal.pone.0300175"},{"key":"12281_CR94","doi-asserted-by":"crossref","unstructured":"Prins H, Coyer L, De Angelis S, Bluemel B, Cauchi D, Baka A. Evaluation of mpox contact tracing activities and data collection in EU\/EEA countries during the 2022 multicountry outbreak in nonendemic countries. J Med Virol. 2024;96(1 C7 - e29352).","DOI":"10.1002\/jmv.29352"},{"issue":"7","key":"12281_CR95","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2105\/AJPH.2023.307301","volume":"113","author":"AB Cope","year":"2023","unstructured":"Cope AB, Kirkcaldy RD, Weidle PJ, Jackson DA, Laramee N, Weber R, et al. Evaluation of public health contact tracing for Mpox among Gay, Bisexual, and other men who have sex with men-10 US Jurisdictions, May 17-July 31, 2022. Am J Public Health. 2023;113(7):815\u20138.","journal-title":"Am J Public Health"},{"issue":"5","key":"12281_CR96","first-page":"4","volume":"30","author":"SA McGee","year":"2023","unstructured":"McGee SA, Russell JA, Metcalf-Kelly M. Enhanced Mpox outbreak case detection among MHS beneficiaries through use of ESSENCE (Electronic surveillance system for the early notification of Community-based Epidemics). Med Surveillance Monthly Rep. 2023;30(5):4\u20138.","journal-title":"Med Surveillance Monthly Rep"},{"key":"12281_CR97","doi-asserted-by":"crossref","unstructured":"Thomas CM, Shaffner J, Johnson R, Wiedeman C, Fill MMA, Jones TF, et al. Lessons learned from implementation of mpox surveillance during an outbreak response in Tennessee, 2022. Public Health Rep. 2024.","DOI":"10.1177\/00333549231223710"},{"key":"12281_CR98","doi-asserted-by":"crossref","unstructured":"Hoff NA, Doshi RH, Colwell B, Kebela-Illunga B, Mukadi P, Mossoko M, et al. Evolution of a disease surveillance system: an increase in reporting of human Monkeypox disease in the Democratic Republic of the Congo, 2001\u20132013. Int J Trop Dis Health. 2017;25(2).","DOI":"10.9734\/IJTDH\/2017\/35885"},{"issue":"3","key":"12281_CR99","doi-asserted-by":"publisher","first-page":"202","DOI":"10.34172\/hpp.2023.25","volume":"13","author":"I Owusu","year":"2023","unstructured":"Owusu I, Adu C, Aboagye RG, Mpangah RA, Acheampong GK, Akyereko E, et al. Preparing for future outbreaks in ghana: an overview of current COVID-19, monkeypox, and Marburg disease outbreaks. Health Promot Perspect. 2023;13(3):202\u201311.","journal-title":"Health Promot Perspect"},{"issue":"4","key":"12281_CR100","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4269\/ajtmh.22-0596","volume":"108","author":"M Rahi","year":"2023","unstructured":"Rahi M, Joy S, Sharma A. Public health challenges in the context of the global spread of Mpox infections. Am J Trop Med Hyg. 2023;108(4):641\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"12281_CR101","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S1473-3099(24)00577-2","volume":"24","author":"K Kuppalli","year":"2024","unstructured":"Kuppalli K, Dunning J, Damon I, Mukadi-Bamuleka D, Mbala P, Ogoina D. The worsening Mpox outbreak in africa: a call to action. Lancet Infect Dis. 2024;24(11):1190\u20132.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"12281_CR102","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.3390\/microorganisms11051186","volume":"11","author":"RP Chauhan","year":"2023","unstructured":"Chauhan RP, Fogel R, Limson J. Overview of diagnostic Methods, disease prevalence and transmission of Mpox (Formerly Monkeypox) in humans and animal reservoirs. Microorganisms. 2023;11(5):C7\u20131186.","journal-title":"Microorganisms"},{"key":"12281_CR103","doi-asserted-by":"crossref","unstructured":"Ferrara P. Mpox vaccination in non-endemic countries: considerations for public health and policy. Vaccines (Basel). 2023;11(9).","DOI":"10.3390\/vaccines11091406"},{"issue":"2","key":"12281_CR104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/JS9.0000000000000142","volume":"109","author":"R Sah","year":"2023","unstructured":"Sah R, Paul D, Mohanty A, Shah A, Mohanasundaram AS, Padhi BK. Monkeypox (Mpox) vaccines and their side effects: the other side of the coin. Int J Surg. 2023;109(2):215\u20137.","journal-title":"Int J Surg"},{"issue":"11","key":"12281_CR105","doi-asserted-by":"publisher","first-page":"e0313325","DOI":"10.1371\/journal.pone.0313325","volume":"19","author":"J Gilmore","year":"2024","unstructured":"Gilmore J, Comer D, Field DJ, Parlour R, Shanley A, Noone C. Recognising and responding to the community needs of gay and bisexual men around Mpox. PLoS ONE. 2024;19(11):e0313325.","journal-title":"PLoS ONE"},{"issue":"1","key":"12281_CR106","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1186\/s12961-024-01123-9","volume":"22","author":"E Manirambona","year":"2024","unstructured":"Manirambona E, Khan SH, Siddiq A, Albakri K, Salamah HM, Hassan NAIF, et al. Intriguing insight into unanswered questions about mpox: exploring health policy implications and considerations. Health Res Policy Syst. 2024;22(1):C7\u201337.","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"12281_CR107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13031-021-00354-9","volume":"15","author":"A Metuge","year":"2021","unstructured":"Metuge A, Omam L-A, Jarman E, Njomo EO. Humanitarian led community-based surveillance: case study in Ekondo-titi, Cameroon. Confl Health. 2021;15(1):17.","journal-title":"Confl Health"},{"key":"12281_CR108","doi-asserted-by":"crossref","unstructured":"Omam L-A, Metuge A. Rapid response mechanism in conflict-affected settings of Cameroon: lessons learned from a multisector intervention for internally displaced persons. J Global Health Rep. 2023;7.","DOI":"10.29392\/001c.85011"},{"issue":"1","key":"12281_CR109","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13031-021-00427-9","volume":"15","author":"L-A Omam","year":"2021","unstructured":"Omam L-A, Jarman E, Ekokobe W, Evon A, Omam EN. Mobile clinics in conflict-affected communities of North West and South West regions of cameroon: an alternative option for differentiated delivery service for internally displaced persons during COVID-19. Confl Health. 2021;15(1):90.","journal-title":"Confl Health"},{"issue":"1","key":"12281_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13031-023-00533-w","volume":"17","author":"L-A Omam","year":"2023","unstructured":"Omam L-A, Jarman E, O\u2019Laughlin KN, Parkes-Ratanshi R. Primary healthcare delivery models in African conflict-affected settings: a systematic review. Confl Health. 2023;17(1):34.","journal-title":"Confl Health"},{"issue":"18","key":"12281_CR111","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3390\/healthcare11182572","volume":"11","author":"A Maccaro","year":"2023","unstructured":"Maccaro A, Audia C, Stokes K, Masud H, Sekalala S, Pecchia L, et al. Pandemic preparedness: a scoping review of best and worst practices from COVID-19. Healthcare. 2023;11(18):2572.","journal-title":"Healthcare"},{"issue":"1","key":"12281_CR112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1740774515618198","volume":"13","author":"HC Lane","year":"2016","unstructured":"Lane HC, Marston HD, Fauci AS. Conducting clinical trials in outbreak settings: points to consider. Clin Trails. 2016;13(1):92\u20135.","journal-title":"Clin Trails"},{"key":"12281_CR113","doi-asserted-by":"crossref","unstructured":"Edwards KM, Kochhar S. Ethics of conducting clinical research in an outbreak setting. 2020.","DOI":"10.1146\/annurev-virology-013120-013123"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12281-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:05:07Z","timestamp":1767798307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12281-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12281"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12281-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented to the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}